Stocks · Healthcare · Medical - Devices
NeuroPace, Inc. NPCE
$12.70 -3.42% Close, Oct 2, 2026 · NASDAQ · Market cap $433.0M
Next earnings report: Nov 3, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- Operating margin widened to -15.3% from -22.4% a year earlier.
- The stock is in a downtrend: below its 200-day average, with the 50-day average below the 200-day.
- Revenue over the last four quarters was $98.8M, up 11.6% from a year earlier, slowing from 18.1% a quarter earlier.
PromtFinance scores
Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 5, 2026.
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Top 45%
- Revenue growth, 3-year CAGRTop 21%
- Revenue growth accelerationBottom 22%
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalTop 49%
- Gross marginTop 31%
- Operating marginBottom 44%
- Accruals (lower is better)Top 41%
- Interest coverBottom 49%
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldTop 42%
- Free-cash-flow yieldTop 45%
- EBITDA / enterprise valueTop 45%
- Sales / enterprise valueBottom 48%
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthTop 33%
- 6-month returnBottom 29%
- 1-year return vs S&P 500Top 40%
- Distance from 52-week highBottom 46%
- Trend checklist (0–4)Bottom 14%
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersTop 20%
- Consecutive EPS beatsBottom 49%
- Share of analysts rating BuyTop 27%
- Upside to consensus price targetBottom 49%
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Top 41%
- Maximum drawdown, 3 yearsTop 44%
- Beta vs S&P 500 (lower is better)Top 35%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | 18.1% | 11.6% | ↓ |
| Gross margin | 75.7% | 79.6% | ↑ |
| Operating margin | -22.4% | -15.3% | ↑ |
| FCF margin | -18.6% | -11.7% | ↑ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | 11.6% | 18.1% | ↓ | Top 45% |
| Gross margin | 79.6% | 75.7% | ↑ | Top 31% |
| Operating margin | -15.3% | -22.4% | ↑ | Bottom 44% |
| Net margin | -19.3% | -29.3% | ↑ | — |
| Free-cash-flow margin | -11.7% | -18.6% | ↑ | — |
| Return on invested capital | -18.4% | — | Top 49% | |
| Revenue growth, 3-year CAGR | 30.0% | — | Top 21% |
Quality of earnings and balance sheet
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- -8.1%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 9.9%
- Receivables growth vs revenue growthReceivables growing much faster than sales can be a warning.
- -1.4 pp
- Interest cover (operating income / interest)How many times operating profit covers interest.
- -2.4×
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 0.00%
- Net buyback yield (TTM)
- -0.48%
- Shareholder yield
- -0.48%
- Share count change, 1 year
- +3.8%
- Share count change, 3-year CAGR
- +10.2%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jun 30, 2026 (filed Aug 11, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 1
- Beats in the last 8 reports
- 6 of 8
- Average EPS surprise, last 4
- +25.0%
- Average 2-day reaction, last 8
- -0.2%
- Positive 20 days after report
- 5 of 8
Analysts
- Consensus price target
- $20.25
- Target vs current price
- +59.4%
- Analysts with a rating
- 10
- Share rating Buy or Strong Buy
- 90%
- Consensus rating
- Buy
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Aug 11, 2026 | +17.4% | +1.1% | -4.0% | -0.8% | — |
| May 12, 2026 | -5.3% | +0.8% | +2.0% | +1.9% | -11.3% |
| Mar 3, 2026 | +42.9% | -2.3% | -0.7% | -9.3% | +20.6% |
| Nov 4, 2025 | +45.0% | +0.0% | +43.1% | +70.4% | +61.0% |
| Aug 12, 2025 | -8.3% | +2.7% | -5.3% | +12.1% | +5.7% |
| May 13, 2025 | +19.2% | -3.1% | +27.2% | -3.2% | -33.3% |
| Mar 4, 2025 | +28.0% | +0.9% | -15.0% | +4.1% | +5.5% |
| Nov 12, 2024 | +26.9% | -1.9% | +22.9% | +58.1% | +72.0% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Aug 11, 2026 | -$0.18 | -$0.22 | +17.4% | $22.8M |
| May 12, 2026 | -$0.20 | -$0.19 | -5.3% | $22.0M |
| Mar 3, 2026 | -$0.08 | -$0.14 | +42.9% | $26.6M |
| Nov 4, 2025 | -$0.11 | -$0.20 | +45.0% | $27.4M |
| Aug 12, 2025 | -$0.26 | -$0.24 | -8.3% | $23.5M |
| May 13, 2025 | -$0.21 | -$0.26 | +19.2% | $22.5M |
| Mar 4, 2025 | -$0.18 | -$0.25 | +28.0% | $21.5M |
| Nov 12, 2024 | -$0.19 | -$0.26 | +26.9% | $21.1M |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| EV / Sales | 4.96× | — | — | Bottom 48% |
| Free-cash-flow yield | -2.68% | — | — | Top 45% |
| Earnings yield | -4.50% | — | — | Top 42% |
Technical state
Trend checklist
- ✗ Price above 20-day average
- ✗ Price above 50-day average
- ✗ Price above 200-day average
- ✗ 50-day average above 200-day
- ✗ MACD histogram positive
Trend quality
- Days above the 50-day average
- 0
- Days above the 200-day average
- 0
- 50-day average slope (20 days)
- -5.6%
- 200-day average slope (20 days)
- -1.0%
- Distance from 50-day average
- -11.1%
- Distance from 200-day average
- -17.1%
- RSI (14)
- 31.4
- Relative volume
- 0.91×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 50.4%
- Volatility vs own 5-year history
- 9th percentile · Low for this stock
- Beta vs S&P 500 (2 years, weekly)
- 0.87
- Correlation with S&P 500
- 0.20
- Current drawdown from 1-year high
- -34.2%
- Maximum drawdown, 3 years
- -66.3%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Apr 27, 2021 | Dec 28, 2022 | -95.1% | 422 days | Not yet recovered |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $433.0M
- EPS, diluted (TTM)
- -$0.57
- Revenue (TTM)
- $98.8M
- 52-week range
- $9.22 – $19.60
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $45.2M | $45.5M | $65.4M | $79.9M | $100.0M |
| Gross profit | $33.4M | $32.5M | $48.1M | $59.1M | $77.2M |
| Operating income | -$23.7M | -$40.8M | -$27.2M | -$21.7M | -$16.3M |
| Net income | -$36.1M | -$47.1M | -$33.0M | -$27.1M | -$21.5M |
| EPS (diluted) | -$2.17 | -$1.91 | -$1.27 | -$0.93 | -$0.66 |
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $21.1M | $21.5M | $22.5M | $23.5M | $27.4M | $26.6M | $22.1M | $22.8M |
| Net income | -$5.5M | -$5.3M | -$6.6M | -$8.7M | -$3.5M | -$2.7M | -$6.7M | -$6.2M |
| EPS (diluted) | -$0.19 | -$0.18 | -$0.21 | -$0.26 | -$0.11 | -$0.08 | -$0.20 | -$0.18 |
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Operating cash flow | -$24.6M | -$36.9M | -$19.7M | -$17.9M | -$11.0M |
| Capital expenditure | -$384,000 | -$603,000 | -$173,000 | -$306,000 | -$332,000 |
| Free cash flow | -$25.0M | -$37.5M | -$19.9M | -$18.3M | -$11.3M |
| Dividends paid | $0 | $0 | $0 | $0 | $0 |
| Net share buybacks | $109.1M | $0 | $7.9M | $3.3M | $22.2M |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $51.7M
- Total assets
- $97.0M
- Total liabilities
- $85.1M
- Total debt
- $69.9M
- Net debt
- $57.4M
- Shareholders’ equity
- $11.9M
As of Jun 30, 2026 (filed Aug 11, 2026).
Short interest
- Shares sold short
- 956,221
- Days to cover
- 8.71
- Change vs previous report
- +4.9%
FINRA short interest, settlement date Sep 15, 2026.